News
Judge temporarily stays CSL acquisition of Talecris
WASHINGTON (Reuters) – Australian blood products group CSL Ltd’s (CSL.AX) takeover of smaller U.S. rival Talecris Biotherapeutics Holdings Corp [TLBIO.UL] has been stayed temporarily, according to a court filing.
U.S. District Judge Colleen Kollar-Kotelly wrote in her ruling that CSL was temporarily restrained from consummating the merger “until such time as this court rules on the commission’s motion for a preliminary injunction.”
The ruling was issued on May 29, when the docket was under seal. That seal has been lifted.
